Ustekinumab
6 Topics Found
Drug Index
Ustekinumab, sold under the brand name Stelara is a monoclonal antibody medication developed by Janssen Pharmaceuticals, for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis,[5] targeting both IL-12 and IL-23.[6] Ustekinumab is approved to treat Crohn's disease in the United States, Israel, Australia, and the European Union (EU), and ulcerative colitis in the US, and in the EU to patients who have not responded to m...
Ustekinumab
Ustekinumab, sold under the brand name Stelara is a monoclonal antibody medication developed by Janssen Pharmaceuticals, for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis,[5] targeting both IL-12 and IL-23.[6] Ustekinumab is approved to treat Crohn's disease in the United States, Israel, Australia, and the European Union (EU), and ulcerative colitis in the US, and in the EU to patients who have not responded to m...
Ustekinumab-auub
Ustekinumab, sold under the brand name Stelara is a monoclonal antibody medication developed by Janssen Pharmaceuticals, for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis,[5] targeting both IL-12 and IL-23.[6] Ustekinumab is approved to treat Crohn's disease in the United States, Israel, Australia, and the European Union (EU), and ulcerative colitis in the US, and in the EU to patients who have not responded to m...
NDC Database
Stelara 130 mg/26ml Intravenous Solution by Janssen Biotech, Inc. ## Package Codes: 57894-054-16, 57894-054-27 ## Active Ingredients: Ustekinumab
NDC Database
Stelara 90 mg/ml Subcutaneous Injection, Solution by Janssen Biotech, Inc. ## Package Codes: 57894-061-02, 57894-061-03, 57894-061-04 ## Active Ingredients: Ustekinumab
NDC Database
Stelara 45 mg/.5ml Subcutaneous Injection, Solution by Janssen Biotech, Inc. ## Package Codes: 57894-060-02, 57894-060-03, 57894-060-04 ## Active Ingredients: Ustekinumab